Martin Begemann

7.9k total citations
7 papers, 161 citations indexed

About

Martin Begemann is a scholar working on Molecular Biology, Cognitive Neuroscience and Genetics. According to data from OpenAlex, Martin Begemann has authored 7 papers receiving a total of 161 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Cognitive Neuroscience and 2 papers in Genetics. Recurrent topics in Martin Begemann's work include Genetics and Neurodevelopmental Disorders (2 papers), Schizophrenia research and treatment (2 papers) and Neural dynamics and brain function (1 paper). Martin Begemann is often cited by papers focused on Genetics and Neurodevelopmental Disorders (2 papers), Schizophrenia research and treatment (2 papers) and Neural dynamics and brain function (1 paper). Martin Begemann collaborates with scholars based in Netherlands, United States and Germany. Martin Begemann's co-authors include Lieuwe de Haan, Selene Veerman, Peter F.J. Schulte, Hannelore Ehrenreich, Marina Mitjans, V. Bansal, Ronald de Vlaming, Richard Karlsson Linnér, Cornelius A. Rietveld and Peter B. Schiff and has published in prestigious journals such as Nature Communications, EMBO Molecular Medicine and NeuroImage Clinical.

In The Last Decade

Martin Begemann

7 papers receiving 158 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin Begemann Netherlands	6	54	53	53	33	20	7	161
Anne Hedemand Denmark	8	90 1.7×	61 1.2×	31 0.6×	17 0.5×	19 0.9×	11	196
Liisa Tomppo Finland	6	136 2.5×	74 1.4×	49 0.9×	22 0.7×	18 0.9×	10	216
M. Plante Canada	7	98 1.8×	142 2.7×	101 1.9×	14 0.4×	16 0.8×	14	337
Thuy Le United States	7	141 2.6×	56 1.1×	26 0.5×	25 0.8×	58 2.9×	8	285
Helen Miranda Knight United Kingdom	10	200 3.7×	100 1.9×	42 0.8×	67 2.0×	31 1.6×	20	338
Steven Biesmans United States	3	87 1.6×	44 0.8×	57 1.1×	60 1.8×	17 0.8×	4	185
Ana P. D. Mendes United States	7	100 1.9×	71 1.3×	80 1.5×	50 1.5×	44 2.2×	7	225
Trine Bjørg Hammer Denmark	9	75 1.4×	83 1.6×	53 1.0×	25 0.8×	37 1.9×	14	215
Inès Khadimallah Switzerland	9	118 2.2×	31 0.6×	37 0.7×	44 1.3×	28 1.4×	16	270
Alex D. Shaw Australia	9	92 1.7×	108 2.0×	41 0.8×	36 1.1×	54 2.7×	10	216

Countries citing papers authored by Martin Begemann

Since Specialization

Citations

This map shows the geographic impact of Martin Begemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Begemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Begemann more than expected).

Fields of papers citing papers by Martin Begemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Begemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Begemann. The network helps show where Martin Begemann may publish in the future.

Co-authorship network of co-authors of Martin Begemann

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Begemann. A scholar is included among the top collaborators of Martin Begemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Begemann. Martin Begemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Spek, Rob van der, Martin Begemann, Lieuwe de Haan, et al.. (2023). fMRI connectivity as a biomarker of antipsychotic treatment response: A systematic review. NeuroImage Clinical. 40. 103515–103515. 5 indexed citations

2.

Bansal, V., Marina Mitjans, Casper A.P. Burik, et al.. (2018). Genome-wide association study results for educational attainment aid in identifying genetic heterogeneity of schizophrenia. Nature Communications. 9(1). 3078–3078. 58 indexed citations

3.

Łepeta, Katarzyna, Katarzyna J. Purzycka, Katarzyna Pachulska‐Wieczorek, et al.. (2017). A normal genetic variation modulates synaptic MMP ‐9 protein levels and the severity of schizophrenia symptoms. EMBO Molecular Medicine. 9(8). 1100–1116. 31 indexed citations

4.

Veerman, Selene, et al.. (2014). Clozapine Augmented with Glutamate Modulators in Refractory Schizophrenia: A Review and Metaanalysis. Pharmacopsychiatry. 47(6). 185–194. 29 indexed citations

5.

Veerman, Selene, Peter F.J. Schulte, Martin Begemann, & Lieuwe de Haan. (2014). Non-Glutamatergic Clozapine Augmentation Strategies: A Review and Meta-Analysis. Pharmacopsychiatry. 47(7). 231–238. 14 indexed citations

6.

Begemann, Martin, et al.. (1998). Treatment of human glioblastoma cells with the staurosporine derivative CGP 41251 inhibits CDC2 and CDK2 kinase activity and increases radiation sensitivity.. PubMed. 18(4A). 2275–82. 23 indexed citations

7.

Begemann, Martin, et al.. (1970). [Determination of human serum-myoglobin].. PubMed. 27. 308–12. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact